Regeneron-1787 for Cutaneous Squamous Cell Carcinoma - Clinical Trial
What is the Purpose of this Study?
We are doing the study to understand how your body reacts to the study drug, Cemiplimab.
Recurrent Cutaneous Squamous Cell Carcinoma (a type of skin cancer that keeps returning)
Who Can Participate in the Study?
Adults with Squamous Cell Carcinoma that keeps coming back.
-The lesion must be about a half inch to one inch across
What is Involved?
If you choose to be in this study, you will:
-Get injected with the study drug (Cemiplimab) for 12 weeks
-Have a Blood draw
-Get a small biopsy of the skin
-Have an x-ray of your chest
-Give a urine sample